IGNEB-IL 1.25 Respule is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains a combination of two bronchodilators, namely ipratropium bromide and levosalbutamol sulfate. Ipratropium bromide helps to relax the muscles in the airways, while levosalbutamol sulfate helps to open up the airways, making it easier to breathe. IGNEB-IL 1.25 Respule is usually administered through a nebulizer and is prescribed by a healthcare professional.